# Questions From the Research Record > Longevity Peptide FAQ — NAD+, MOTS-c, Epitalon — New Age Peptide — Frequently asked questions about three Longevity & Cellular Health research compounds — NAD+, MOTS-c and Epitalon — answered from the peer-reviewed literature, with citations. **LONGEVITY & CELLULAR HEALTH / FAQ** Direct, citation-anchored answers to the questions readers most often bring to NAD+, MOTS-c and Epitalon. ## What is NAD supplement used for? NAD+ supplements are sold as a way to raise the body's level of nicotinamide adenine dinucleotide, a coenzyme cells use to make energy and repair DNA that declines with age. Most products are actually NAD+ *precursors* — NMN or NR — rather than NAD+ itself, since NAD+ is poorly absorbed intact. In clinical trials, oral NMN improved walking distance and quality-of-life scores at 600 mg/day over 60 days [2] and improved muscle insulin sensitivity in prediabetic women at 250 mg/day over 10 weeks [3]. These are trial results, not a use recommendation for any individual. ## What is the downside of taking NAD+? The main downsides documented in the literature are: the evidence that raising blood NAD+ actually changes a clinical outcome remains limited, per a 2025 review [1]; IV/injectable NAD+ therapy is marketed more aggressively than its evidence supports, and fast infusions have been linked to chest or abdominal discomfort, flushing and nausea; at least one compounded injectable NAD+ product was subject to an FDA Class I recall for bacterial contamination; and NAD+ supports proliferating cells in general, raising a theoretical (not proven) concern in cancer contexts. NMN's supplement status is also legally contested in the US. None of this is a reason to conclude NAD+ is dangerous — it is a reason to read the specific claim behind any given product rather than the category as a whole. ## Is it safe to take NAD daily? In the published randomized trials, daily oral dosing of the precursors NMN (up to 900 mg/day for 60 days) [2] and NR (up to 1000 mg/day for 8 weeks) [5] was well tolerated, with no significant difference in adverse events versus placebo at any dose tested. That reflects trial findings over the specific study durations tested — it is not a safety guarantee for indefinite daily use, and it does not extend to compounded IV or injectable NAD+ products, which carry a separately documented contamination risk. This is a summary of what trials found, not medical advice for any individual. ## Does NAD cause weight gain? The published trial evidence does not identify weight gain as a documented effect of NAD+ precursor supplementation. In one 10-week RCT of NMN in prediabetic, postmenopausal women, body composition was unchanged despite an improvement in muscle insulin sensitivity [3]. No trial in the corpus behind this site reports weight gain as an outcome. ## What does the MOTS-c peptide do? MOTS-c is a 16-amino-acid peptide encoded inside the mitochondrial genome. In animal and cell studies, it activates AMPK (a cellular energy-sensing enzyme) via inhibition of the folate cycle, improving glucose handling, and it directly binds and activates casein kinase 2 (CK2) in a tissue-specific way that has been linked to preventing muscle atrophy and improving muscle glucose uptake [8]. Under metabolic stress it also moves into the cell nucleus to help regulate gene expression [12]. All of this evidence is from cell and mouse studies; no human interventional trial of MOTS-c has been published. ## What are the negative side effects of MOTS-c? There is no published human safety or side-effect data for MOTS-c, because no human interventional trial has been conducted. What exists instead is a set of open cautions: no validated human dose, half-life, or bioavailability data exist; research-market material is unregulated, so purity and identity vary by supplier; and MOTS-c is treated as a prohibited substance under anti-doping rules, which can carry sanctions for athletes independent of any safety question. ## Is MOTS-c legal to buy? In the US, MOTS-c is generally sold as a research chemical labeled 'not for human consumption,' which is a different legal category from an approved medicine or supplement — it means the product is intended for laboratory research use, not that it has been evaluated as safe or effective for people. It is not FDA-approved for any human use, and it is treated as a prohibited substance under anti-doping rules in competitive sport. This page describes the regulatory framing; it is not legal advice and does not recommend acquiring or using the compound. ## How often do you inject MOTS-c? There is no established human injection protocol for MOTS-c, because no human interventional trial has published dosing or frequency data. Mouse studies have used daily doses in the range of roughly 0.5–15 mg/kg/day, but animal doses cannot be responsibly converted into a human schedule, and this site does not do so. Anyone encountering a specific 'protocol' online is reading an unverified, non-clinical source. ## What is epitalon? Epitalon (also spelled Epithalon) is a synthetic four-amino-acid peptide — Ala-Glu-Asp-Gly — modeled on the amino-acid composition of epithalamin, an extract of the bovine pineal gland. It is studied mainly for two proposed effects: activating telomerase, the enzyme that maintains the protective ends of chromosomes, and stimulating pineal melatonin synthesis. It is not approved by the FDA, EMA or MHRA for any human use and is classified as a research chemical [13]. ## What are the benefits of epitalon according to research? In cell-culture studies, Epitalon has been shown to upregulate telomerase activity and extend telomere length in normal human cells [14][16], and to stimulate the melatonin-synthesis pathway in pineal cell culture [15]. An observational study in elderly people found an association between a related pineal peptide and reduced mortality over 6–8 years, though that study was not randomized or placebo-controlled [17]. Outside formal trials, community reports describe things like better sleep and a general sense of well-being, but that is anecdotal, not clinical evidence, and a commonly reported outcome in the same communities is no noticeable effect at all. ## What is the recommended dosage of epitalon in research protocols? No clinically established human dose exists for Epitalon — there is no published human pharmacokinetic study to base one on. The cell-culture studies behind its telomerase findings used concentrations of roughly 0.1–1 µg/mL applied directly to cultured cells [14], which is a laboratory measurement, not a human dose, and cannot be converted into one. This site does not recommend a dose to any person. ## How often should epitalon be cycled, once or twice a year? This is a question about a self-administration protocol, and it has no clinical answer to give: no controlled human trial has tested a cycling schedule for Epitalon, once, twice, or any other frequency per year. Cycling patterns discussed in longevity and biohacking communities are self-reported practices, not clinically validated protocols, and this site does not recommend any schedule. The honest state of the evidence is that Epitalon's human data comes from one observational cohort study using a related pineal peptide, not a randomized dosing trial [17]. --- This is a reading room, not a remedy — every claim traces to a cited study, and no page here sells a peptide or promises a longer life.